Browse the evidence

Higher abundance of Blautia is associated with higher levels of saturated and monounsaturated fatty acids, while lower abundance is associated with polyunsaturated fatty acids, suggesting a link between specific bacterial genera and lipid metabolism.

The type of fat in your diet may influence which bacteria thrive in your gut. A diet high in saturated fats might favor Blautia, while polyunsaturated fats might favor other taxa. This is a correlation, not a prescription, but it suggests dietary fats shape your microbial ecosystem.

Higher plasma TMAO levels are associated with higher abundance of Prevotella and Peptococcaceae, and lower abundance of Faecalibacterium prausnitzii, linking gut microbiota to a metabolite associated with cardiovascular risk.

TMAO, a metabolite linked to heart disease risk, is produced by gut bacteria from dietary components. Your gut bacteria composition affects your TMAO levels. Maintaining a healthy microbiome through a diverse diet may help manage TMAO levels, but this is one factor among many for cardiovascular health.

Chronic senescence, driven by accumulated cellular stress and defective clearance mechanisms, is a primary driver of biological aging and age-related diseases, whereas acute senescence serves beneficial roles in development and tissue repair.

Aging is not just 'wear and tear' but involves specific cells (senescent cells) that stop dividing but secrete inflammatory factors (SASP) that damage surrounding tissue. As we age, our immune system becomes less efficient at clearing these cells, leading to accumulation and disease. Current research focuses on 'senolytics' (drugs that kill these cells) to potentially improve health in the elderly, though no universally accepted biomarker or treatment is yet standard.

Lymphocyte proportion in skeletal muscle is lower in young females compared to other demographic groups (young males, old males, old females).

Young women may have distinct immune cell profiles in muscle compared to men or older women. This does not change training advice but highlights biological differences in immune response.

DNA methylation-based epigenetic clocks serve as accurate biomarkers for predicting biological age, disease risk, and mortality, often outperforming traditional chronological age metrics.

Use epigenetic age as a diagnostic tool to assess your biological aging rate relative to your chronological age. While you cannot change your birth date, tracking these biomarkers (via blood tests) can help identify early risks for diseases like diabetes, cardiovascular issues, or cognitive decline, allowing for earlier lifestyle or medical interventions.

Specific DNA methylation alterations in blood (e.g., ABCG1, TXNIP, SLC30A8) can predict the onset of Type 2 Diabetes (T2D) prior to clinical diagnosis, offering a window for early detection.

If you have risk factors for Type 2 Diabetes (high BMI, family history), ask your doctor about emerging epigenetic biomarkers if available. While not yet standard of care, these tests may detect metabolic risk earlier than blood sugar tests, allowing for earlier lifestyle interventions.

Epigenetic age acceleration, measured by DNA methylation clocks, is associated with increased risk of Cardiovascular Disease (CVD) and mortality.

Maintain cardiovascular health through lifestyle choices (diet, exercise, no smoking) as these factors influence epigenetic aging. While you cannot change your chronological age, keeping your epigenetic age close to your chronological age is associated with lower CVD risk and longer life expectancy.

Obesity in older American adults is associated with a distinct gut microbiome taxonomic signature characterized by reduced species richness and specific shifts in bacterial abundance, including increased Bacilli (Streptococcaceae, Lactobacillaceae) and decreased Clostridia (Christensenellaceae, Clostridiaceae).

Your gut bacteria look different when you are obese, specifically with fewer diverse species and lower levels of certain beneficial bacteria like Christensenellaceae. While this doesn't tell you how to fix it directly, it suggests that restoring microbial diversity might be a valid area for dietary intervention, rather than focusing on simple 'good vs bad' bacteria ratios.

Post-hoc statistical calibration of self-reported data using biomarkers can correct for underreporting, though it often results in small effect sizes for disease outcomes.

If you are reading research on diet and disease, check if they used biomarker calibration. Uncalibrated self-report studies may show misleading inverse relationships (e.g., claiming sugar protects against diabetes).

In tertiary-care diabetic populations, comprehensive management of glycemic, lipid, and blood pressure targets (ABC control) remains suboptimal, with only 20.2% of patients achieving all preset control goals despite high medication availability.

For patients managing diabetes, simply having access to medication is not enough to guarantee health outcomes. This data suggests that achieving comprehensive control (blood sugar, lipids, and blood pressure) is difficult, with only 1 in 5 patients succeeding in a high-resource setting. Focus on the 'why' behind uncontrolled numbers, as medication availability alone does not solve the metabolic burden.

Chronic vascular complications, including retinopathy, nephropathy, neuropathy, and ischemic heart disease, are highly prevalent in diabetic populations, with over half of patients exhibiting at least one complication.

More than half of diabetic patients in this study had at least one chronic complication, such as eye, kidney, nerve, or heart issues. This highlights the critical importance of regular screening for complications, even if you feel healthy, as damage can be silent.

FMT from lean donors successfully engrafts donor-specific bacteria in the majority of obese recipients, with effects persisting for at least 12 weeks, although the degree of engraftment varies significantly by donor.

FMT from lean donors can successfully introduce new bacteria into your gut, and these changes can last for months. However, this microbial change alone does not guarantee improvements in insulin sensitivity or weight loss.

Positive Airway Pressure (PAP) therapy is the primary medical treatment for Obstructive Sleep Apnea (OSA) and significantly reduces daytime sleepiness and apnea-hypopnea index (AHI), though its impact on cardiovascular mortality and hard endpoints remains less definitive.

If you have OSA, PAP therapy is the most effective way to keep your airway open and reduce sleepiness. You need to find the right pressure and mask type, which may take some trial and error, but sticking with it is crucial for your long-term health and quality of life.

Surgical interventions and oral appliances are alternative treatments for OSA, with efficacy varying by patient anatomy and severity, often serving as options when PAP is not tolerated.

If PAP doesn't work for you, talk to your doctor about surgical options or oral appliances. These can be effective for some people, especially if your anatomy is suitable, but they require careful evaluation.

Mendelian randomization using semiparametric methods (fractional polynomial or piecewise linear) reveals that the causal relationship between BMI and systolic blood pressure is nonlinear, showing a steep increase up to a BMI of ~32 kg/m2 and a flatter or slightly negative slope thereafter, while the relationship with diastolic blood pressure increases almost linearly up to ~40 kg/m2.

For individuals with a BMI between 25 and 32, blood pressure tends to rise sharply with each unit of BMI. However, once BMI exceeds 32, the rate of blood pressure increase may slow down or even slightly decrease, suggesting a complex biological interaction rather than a simple linear progression. For Diastolic Blood Pressure, the increase remains relatively linear up to a BMI of 40. This implies that weight management strategies might have different impacts on blood pressure depending on the starting BMI and the type of blood pressure being monitored.

Ultra-marathon running can lead to temporary pathological changes in organ systems, including the heart, liver, kidneys, and immune system, which typically normalize after the race.

Don't panic if you feel unwell or see abnormal blood work after an ultra-marathon. The paper notes that changes in heart, liver, and kidney biomarkers are common but usually temporary and normalize after recovery. Focus on rest and hydration to allow your body to heal.

There is no significant association between the frequency of consuming home-cooked meals and markers of cholesterol, HbA1c, or hypertension after adjusting for sociodemographic and dietary covariates.

Do not expect home-cooked meals to directly improve cholesterol, HbA1c, or blood pressure levels based on this study alone, as these markers were not significantly associated with meal frequency after adjusting for other factors.

Among US adults, non-Hispanic Black individuals exhibited a significant decrease in lean body mass from 2011 to 2018, while other racial/ethnic groups maintained stable or increased lean mass.

For non-Hispanic Black adults, population data indicates a concerning trend of declining lean mass. To counter this, prioritize resistance training and adequate protein intake, as these are the primary levers for maintaining muscle mass, regardless of broader demographic trends.

In Korean adults aged 30 and older, diabetes prevalence is 13.7% (4.8 million) and impaired fasting glucose (prediabetes) prevalence is 24.8% (8.3 million), with prevalence increasing significantly with age and lower family income.

If you are over 30, your risk of diabetes or prediabetes is significant, especially if you have lower income. Get screened regularly. Prediabetes (IFG) is highly prevalent and is a warning sign that lifestyle changes can prevent progression to full diabetes.

Comorbidities including obesity (48.6%), hypertension (54.7%), and hypercholesterolemia (31.6%) are highly prevalent in Korean adults with diabetes, yet control rates for these conditions are suboptimal.

Diabetes rarely comes alone. Nearly half of diabetic adults are obese, and more than half have high blood pressure. Managing your weight and diet is crucial not just for blood sugar, but for controlling blood pressure and cholesterol, which together determine your heart health.

Higher genetic liability for GrimAge acceleration (a DNA methylation-based biomarker of biological aging) is causally associated with greater adiposity, current tobacco smoking, and lower educational attainment, while being inversely associated with parental longevity.

Your biological age, measured by DNA methylation patterns (GrimAge), is strongly linked to your weight, smoking status, and education level. Maintaining a healthy weight and avoiding smoking can significantly slow down this specific marker of biological aging, potentially extending healthspan and longevity.

Genetic variants associated with Intrinsic Epigenetic Age Acceleration (IEAA) are enriched in pathways related to lipid metabolism, immune function, and hematopoietic stem cell properties, independent of DNA methylation levels at the clock's constituent CpG sites.

Research shows that your genetic makeup influences how your body ages through immune and lipid pathways. While you cannot change your genes, understanding these links highlights the importance of managing inflammation and lipid levels for healthy aging.

Maternal overweight/obesity increases the risk of childhood overweight/obesity, with the magnitude of risk being significantly higher for cesarean-delivered infants compared to vaginally delivered infants, mediated sequentially by birth mode and infant gut microbiota (specifically Firmicutes richness and Lachnospiraceae abundance).

For mothers with overweight or obesity, be aware that both vaginal and cesarean delivery carry an increased risk of childhood overweight compared to normal-weight mothers, with cesarean delivery showing a higher risk. This risk is partly mediated by the infant's gut microbiota, specifically the abundance of Lachnospiraceae. While birth mode cannot be changed post-delivery, understanding this link highlights the importance of early gut health. Postnatal factors such as breastfeeding, diet, and antibiotic exposure also shape the microbiome and may offer opportunities to mitigate risk.

Global efforts to reduce malnutrition have been more than offset by a rapidly rising obesity burden, resulting in a widening 'double burden' of disease where obesity-related disability-adjusted life years (DALYs) now vastly exceed malnutrition-related DALYs.

Global health strategies must stop treating hunger and obesity as separate issues. As countries develop and reduce starvation, they often swing into obesity epidemics. Effective policy requires a unified approach that ensures food security while simultaneously preventing the shift toward unhealthy, obesity-driving diets, particularly in low-to-middle income regions undergoing rapid economic change.